small molecule

ALBUTEROL SULFATE

ALBUTEROL SULFATE

Loss of exclusivityDecember 2026FDA regulatory exclusivity expiry
CompanyCiplaSee this company's full patent-cliff portfolio

Drug detail

Brand nameALBUTEROL SULFATE
Active ingredientALBUTEROL SULFATE
StrengthEQ 0.09MG BASE/INH
Dosage formAEROSOL, METERED
RouteINHALATION
ModalitySmall molecule
FDA approvalApril 2026
Marketing statusRX

Regulatory exclusivity

CodeExpires
CGTDecember 2026

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the FDA regulatory exclusivity expiry; estimates are projections, not legal advice.

ALBUTEROL SULFATE patent cliff — loss of exclusivity December 2026 | CliffBio